[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n D5kfFzNayfIkLu5lFwYAx/aMtrXzo2ccSd0mqThfdgopBjcXvz2bCidEKXLayDit\n egd9DrV4nEIpdIEuPu0kmQ==\n\n', u'0001193125-04-164828.txt : 20040930\n', u'0001193125-04-164828.hdr.sgml : 20040930\n', u'20040930162731\nACCESSION NUMBER:\t\t0001193125-04-164828\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t6\nCONFORMED PERIOD OF REPORT:\t20040930\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nITEM INFORMATION:\t\tFinancial Statements and Exhibits\nFILED AS OF DATE:\t\t20040930\nDATE AS OF CHANGE:\t\t20040930\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tNDCHEALTH CORP\n\t\tCENTRAL INDEX KEY:\t\t\t0000070033\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tSERVICES-BUSINESS SERVICES, NEC [7389]\n\t\tIRS NUMBER:\t\t\t\t580977458\n\t\tSTATE OF INCORPORATION:\t\t\tDE\n\t\tFISCAL YEAR END:\t\t\t0531\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-12392\n\t\tFILM NUMBER:\t\t041055527\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\tNDCHEALTH CORPORATION\n\t\tSTREET 2:\t\tNDC PLAZA\n\t\tCITY:\t\t\tATLANTA\n\t\tSTATE:\t\t\tGA\n\t\tZIP:\t\t\t30329\n\t\tBUSINESS PHONE:\t\t4047282000\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\tNDC PLAZA\n\t\tCITY:\t\t\tATLANTA\n\t\tSTATE:\t\t\tGA\n\t\tZIP:\t\t\t30329-2010\n\n\tFORMER COMPANY:\t\n\t\tFORMER CONFORMED NAME:\tNATIONAL DATA CORP\n\t\tDATE OF NAME CHANGE:\t19920703\n', u'\n', u'\n', u'8-K\n', u'1\n', u'd8k.htm\n', u'FORM 8-K\n', u'\n', u'Form 8-K', u'\n', u' ', u'UNITED STATES ', u' ', u'SECURITIES AND EXCHANGE COMMISSION ', u' ', u'Washington, D.C. 20549 ', u' ', u'\xa0', u' ', u'\xa0', u' ', u'FORM 8-K ', u' ', u'\xa0', u' ', u'\xa0', u' ', u'CURRENT REPORT ', u' ', u'Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ', u' ', u'\xa0', u' ', u'Date of Report (Date of earliest event reported): September 30, 2004 ', u' ', u'\xa0', u' ', u'Commission File No. 001-12392 ', u' ', u'\xa0', u' ', u'\xa0', u' ', u'NDCHealth Corporation ', u' ', u'(Exact name of registrant as specified in its charter)\n', u' ', u'\xa0', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'DELAWARE', u'\n', u'\xa0', u'\n', u'58-0977458', u'\n', u'\n', u' ', u'(State or other jurisdiction', u' ', u'of incorporation)', u'\n', u'\xa0', u'\n', u' ', u'(IRS Employer', u' ', u'Identification Number)', u'\n', u'\n', u'\n', u'\n', u'\n', u'NDC Plaza, Atlanta, Georgia', u'\n', u'\xa0', u'\n', u'30329-2010', u'\n', u'\n', u'(Address of principal executive offices)', u'\n', u'\xa0', u'\n', u'(Zip Code)', u'\n', u' ', u'\xa0', u' ', u'Registrant\x92s\ntelephone number, including area code (404) 728-2000 ', u' ', u'\xa0', u' ', u'None ', u' ', u'(Former name or former address, if changed since last report.) ', u' ', u'\xa0', u' ', u'\xa0', u' ', u'Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):\n', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa8', u'\n', u'Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa8', u'\n', u'Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa8', u'\n', u'Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa8', u'\n', u'Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ', u' ', u'\xa0', u'\n', u'\n', u'ITEM 2.02 Results of Operations and Financial Condition. ', u' ', u'\xa0', u' ', u'On September 30, 2004, NDCHealth Corporation issued a press release\nannouncing financial results for its first quarter of fiscal 2005 ended August 27, 2004. The full text of the press release is attached as exhibit 99.1. ', u' ', u'\xa0', u' ', u'The information in this Current Report on Form 8-K, including exhibits 99.2 through 99.5 attached hereto, is being furnished and shall not be deemed\n\x93filed\x94 for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into future filings under the Securities Act of 1933, as amended, or under the Securities Exchange Act of\n1934, as amended, unless expressly set forth in such future filing that such information is to be considered \x93filed\x94 or incorporated by reference therein. ', u' ', u'\xa0', u' ', u'ITEM 9.01 Financial Statements and Exhibits. ', u' ', u'\xa0', u' ', u'(c) Exhibits ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'Exhibit', u'Number', u'\n', u'\xa0', u'\n', u' ', u'Exhibit Title', u'\n', u'\n', u'99.1', u'\n', u'\xa0', u'\n', u'Press Release dated September 30, 2004.', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.2', u'\n', u'\xa0', u'\n', u'EBITDA Reconciliation.', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.3', u'\n', u'\xa0', u'\n', u'Free Cash Flow Reconciliation.', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.4', u'\n', u'\xa0', u'\n', u'Segment Financial Summary.', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.5', u'\n', u'\xa0', u'\n', u'Network Services and Systems Segment Revenue by Customer Group.', u'\n', u' ', u'\xa0', u'\n', u'\n', u'SIGNATURE', u' ', u' ', u'\xa0', u' ', u'Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed\non its behalf by the undersigned hereunto duly authorized. ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'NDCHealth Corporation', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0(Registrant)', u'\n', u'\n', u'\n', u'\n', u'\n', u'By:', u'\n', u'\xa0', u'\n', u' ', u'/s/ James W. FitzGibbons', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'James W. FitzGibbons', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Vice President and Chief Accounting Officer', u'\n', u' ', u'\xa0', u' ', u'Date: September 30, 2004\n', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'EX-99.1\n', u'2\n', u'dex991.htm\n', u'PRESS RELEASE\n', u'\n', u'Press Release', u'\n', u'Exhibit 99.1 ', u' ', u'\xa0', u' ', u'NDCHealth Reports Fiscal First Quarter Results ', u' ', u'\xa0', u' ', u'ATLANTA, September 30, 2004', u' \x96 NDCHealth Corporation (NYSE: NDC) today reported financial and operating results for its first\nquarter of fiscal 2005 ended August 27, 2004. Total revenue from continuing operations increased 4.9% to $108.7 million from $103.6 million in the first quarter of fiscal 2004. Income from continuing operations was $1.1 million, or $0.03 per diluted\nshare, compared to $7.9 million, or $0.22 per diluted share, in the same period a year ago. Net loss after discontinued operations was $7.0 million, or $0.19 per diluted share, compared to net income of $7.4 million, or $0.21 per diluted share, in\nthe first quarter of fiscal 2004. ', u' ', u'\xa0', u' ', u'First quarter revenue was\ndriven by significant growth in Pharmacy Benefit Services, offset by seasonal declines in both the Network Services and Systems and Information Management segments. The decline in Network Services and Systems segment revenue was primarily caused by\nlower physician software sales and the transition to next-generation pharmacy systems, which offset solid growth in Pharmacy network services. The Information Management segment generated lower revenue from non-recurring analytic studies and was\nimpacted by price compression from certain pharmaceutical manufacturer customers renewed during the last year. ', u' ', u'\xa0', u' ', u'\x93We are experiencing growth in our Network transaction services and Pharmacy Benefit Services. However, as expected, a significant decline in\nphysician software sales and lower Information Management revenue continued to impact our financial performance in what is historically our seasonally weakest quarter,\x94 said Walter Hoff, chairman and CEO, NDCHealth. \x93We clearly recognize\nthe need to improve our revenue and profit performance, and we remain focused on accelerating product sales and implementations. We expect the combination of revenue growth and appropriate expense control initiatives will deliver sequential profit\nexpansion each quarter beginning in the second quarter of fiscal 2005. ', u' ', u'\xa0', u' ', u'\x93Our customers continue to demand high quality solutions that can deliver much needed operating efficiencies and financial benefits, and our strategies are set to capitalize on this trend,\x94 Mr. Hoff continued. \x93We are making\nprogress in implementing new product and service offerings at attractive pricing levels, and our current and new sales opportunities should support improved revenue growth in the coming quarters. We will continue to take a disciplined approach in\nour efforts to maximize revenue growth, profitability and cash flow while growing market share with our new customer solutions.\x94 ', u' ', u'\xa0', u' ', u'Business Highlights ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\x95', u'\n', u'Network Services and Systems', u' segment revenue declined $5.5 million or 8.8% in the first quarter of fiscal 2005 from the same period last year. This decrease was primarily\ncaused by lower physician software sales and the transition to next-generation pharmacy systems, which more than offset revenue growth from pharmacy network services. ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\x95', u'\n', u'Network services\x92 transaction volume totaled more than 1.35 billion in the first quarter of fiscal 2005, a 17.4% increase from the same period last year and up 5.0%\nsequentially as the company continued to gain market share and increase penetration of its value-adding transaction services. ', u' ', u'\xa0', u' ', u'\xa0', u' ', u'\xa0', u' ', u'- more - ', u'\n', u'\n', u'NDCHealth Reports Fiscal First Quarter Results ', u' ', u'Page 2 ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\x95', u'\n', u'Pharmacy services and systems revenue decreased $0.9 million or 2.5% in the first quarter compared to the same quarter of fiscal 2004. Pharmacy transaction revenues grew but were\nmore than offset by lower retail pharmacy information sales as well as lower pharmacy systems revenue. New NDC PharmacyRx', u'\x99', u' (formerly T-Rex One) system sales and the transition to recurring, transaction-based revenue have not yet offset a decrease in legacy systems sales.\nNDCHealth sold 55 PharmacyRx system solutions to regional and independent pharmacies during the first quarter of fiscal 2005, and ended the period with an installed base of 281 pharmacies. The company expects to continue to increase its installed\nbase of PharmacyRx systems through the year, but expects that year-to-year pharmacy systems revenue will be flat to down until the company\x92s NDC EnterpriseRx', u'\x99', u' system for large pharmacy chains is available and begins to generate revenue, which is currently expected in the fourth\nquarter of fiscal 2005. Growth in pharmacy services during fiscal 2005 is expected to cause total revenue from pharmacy customers to increase from first quarter levels. ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\x95', u'\n', u'Hospital customer revenue decreased $0.3 million or 1.9% in the first quarter of fiscal 2005 compared to the same period in fiscal 2004 and was flat sequentially as accelerating\nrevenue growth from NDC ePREMIS', u'\x99', u' continued to be\noffset by a decline in legacy systems revenue. The company sold 40 ePREMIS units and installed 109 units during the first quarter of fiscal 2005, increasing the total ePREMIS installed base since May 2004 by 47% to 340. As of August 27, 2004, the\nscheduled installation backlog moving into the second quarter of fiscal 2005 was 265 units. New unit sales are expected to increase in the second quarter from the reduced level of the summer months, and installations should continue at a similar\npace. These unit sale and installation trends are expected to lead to increasing revenues from hospital customers through the remainder of the fiscal year. ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\x95', u'\n', u'Physician customer revenue in the first quarter of fiscal 2005 decreased $0.2 million or 3.9% from the most recent fourth quarter, and declined $4.0 million or 39.8% from the first\nquarter of fiscal 2004. This reflects fewer system sales as a result of some continuing effect of the recent change to selling software to value added resellers on a cash basis instead of on credit terms as well as a lower sales volume during the\nsummer months. The company expects physician system sales to begin to recover in the upcoming second quarter following the release of product upgrades as value added resellers purchase software with the new HIPAA security functionality.\n', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\x95', u'\n', u'Other revenue, which includes data processing services provided to former affiliate Global Payments, Inc. and third-party paper claims and statement printing services, declined\n11.2% compared with the first quarter last fiscal year to $3.5 million. As previously disclosed, Global Payments may discontinue the service agreement on September 30, 2005, eliminating a portion of this revenue stream within approximately the next\ntwelve months. ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\x95', u'\n', u'Information', u' ', u'Management', u' revenue in the first quarter of fiscal 2005 decreased $1.0 million or 2.8% compared to the same quarter last year. Lower revenue from\nnon-recurring ad hoc analytic studies and price compression from certain of the company\x92s pharmaceutical manufacturer customers contributed to the decline. This offset growth in new product revenue from the company\x92s Insight and Impact\nproduct suites and Intelligent Health Repository, which together increased more than 100% from the first quarter of fiscal 2004 to $3.3 million. Future growth is expected to be derived from the company\x92s differentiated and exclusive new\ninformation sets as well as from increased customer spending on strategic analytic studies as new drugs are approved by the Food and Drug Administration. ', u' ', u'\xa0', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\x95', u'\n', u'Pharmacy Benefit Services', u' revenue more than tripled in the first quarter of fiscal 2005 compared to the same period in fiscal 2004 due to the rapid expansion of the\nadministrative services component, and ', u' ', u'\xa0', u' ', u'- more -\n', u'\n', u'\n', u'NDCHealth Reports Fiscal First Quarter Results ', u' ', u'Page 3 ', u' ', u'\xa0', u' ', u'comprised 14.9%\nof total company revenue in the quarter. Because a majority of the revenue in the Pharmacy Benefit Services segment includes the underlying prescription drug cost of the pharmacy benefit programs being managed, margins are low and reported revenue\ngrowth in the segment is not expected to be a significant profit contributor in the near term. ', u' ', u'\xa0', u' ', u'Cost of Service increased $14.7 million from the first quarter of fiscal 2004. This increase reflects primarily strong growth in revenue and associated Cost of Service in the Pharmacy Benefit Services segment. Cost of\nService increased by $2.7 million in the Network Services and Systems segment over the prior year due primarily to increased software development expense and by $0.6 million in the Information Management segment due to increased data costs and\noperating costs associated with the ArcLight integration, partially offset by lower staffing costs associated with ad hoc research studies. ', u' ', u'\xa0', u' ', u'Sales, General and Administrative expenses in the first quarter of fiscal 2005 rose 7.8% or $1.7 million from a year ago but declined by $2.9 million or\n10.9% sequentially from the fourth quarter of fiscal 2004. The increase from a year ago was due to higher legal, audit and insurance expenses and increased staffing and other costs associated with regulatory requirements. ', u' ', u'\xa0', u' ', u'In the first quarter of fiscal 2005, EBITDA', u'a', u', a non-GAAP measure, was $18.8 million. Free cash flow', u'b', u', also a non-GAAP measure, was a negative $19.1 million in the quarter, reflecting the reduced level of income, a reduction in accounts payable, the timing of\npayment of accrued liabilities and payroll, and the company\x92s $10.5 million semi-annual payment of interest on outstanding bonds. Free cash flow is expected to improve through the remainder of fiscal 2005. ', u' ', u'\xa0', u' ', u'As previously disclosed, NDCHealth\x92s board of directors authorized the\nsale of its European operations, which are recorded as discontinued operations. The company is negotiating with interested buyers, and anticipates consummating a transaction by the end of December 2004. The operating loss from the European\nbusinesses was $0.5 million, or $0.01 per share, in the first quarter of fiscal 2005. In the first quarter of fiscal 2005, however, management determined the company will receive lower than previously expected total transaction proceeds based on\ncurrent negotiations. As a result, the carrying value of this asset was reduced, which increased the Loss from Discontinued Operations by $7.6 million, or $0.21 per share. As a result, total Loss from Discontinued Operations was $8.1 million, or\n$0.22 per diluted share. ', u' ', u'\xa0', u' ', u'Outlook ', u' ', u'\xa0', u' ', u'The company expects second quarter revenue to be in the range of $112\nmillion to $117 million, which includes $16 million to $18 million in revenue from Pharmacy Benefit Services. Revenue from the Network Services and Systems and Information Management segments combined should be in the range of $96 million to $99\nmillion, up 4% to 7% from the first quarter of fiscal 2005. Each of NDCHealth\x92s businesses are expected to experience moderate sequential growth. Diluted earnings per share from continuing operations should be between $0.04 and $0.08 in the\nsecond quarter. Based on these estimates and other factors, the company expects free cash flow to be breakeven to modestly positive in the second quarter, and positive for the second half of fiscal 2005. ', u' ', u'\xa0', u' ', u'The company expects revenue and earnings per share to increase each quarter\nsequentially through the remainder of the year, reflecting growth in revenue from the sale and implementation of newer services for the company\x92s information, pharmacy and hospital customers, a recovery in revenue from physician products and\nservices, and continued expense management. ', u' ', u'\xa0', u' ', u'- more -\n', u'\n', u'\n', u'NDCHealth Reports Fiscal First Quarter Results ', u' ', u'Page 4 ', u' ', u'\xa0', u' ', u'Conference Call for Analysts\nand Investors ', u' ', u'\xa0', u' ', u'NDCHealth management will host a conference\ncall to discuss these results today, September 30, 2004 beginning at 5:00 pm ET. The conference call can be accessed by dialing 877-421-3895 (706-679-0822 for international/local callers), or by web cast through the Investor Relations page at\nhttp://www.ndchealth.com. A replay of the conference call will be available through October 15, 2004, and can be accessed either through the web cast or by dialing 800-642-1687 (706-645-9291 for international/local callers) and entering conference\nID 75939. ', u' ', u'\xa0', u' ', u'Cautionary Information Regarding Forward-Looking Statements\n', u' ', u'\xa0', u' ', u'This press release contains forward-looking statements\nrelated to the company\x92s expected business outlook for fiscal year 2005 and guidance for the second fiscal quarter of 2005. These statements involve risks and uncertainties that may cause actual results to differ materially. The company\x92s\nbusiness outlook and the projected results for future periods are based on preliminary estimates, assumptions and projections that management believes to be reasonable at this time, but may be beyond management\x92s control. Forward-looking\nstatements are only predictions and are not guarantees of performance, and include statements preceded by, followed by or that include the words \x93may,\x94 \x93could,\x94 \x93would,\x94 \x93should,\x94 \x93believe,\x94\n\x93expect,\x94 ', u'\x93anticipate,\x94 \x93plan,\x94 \x93estimate,\x94 \x93target,\x94 \x93project,\x94 \x93intend,\x94 or similar expressions. These statements include, among others, statements regarding the\ncompany\x92s expected business outlook, anticipated financial and operating results, its business strategy and means to implement the strategy, the company\x92s objectives, the amount and timing of future capital expenditures, the likelihood of\nthe company\x92s success in developing and introducing new products and expanding its business, the timing of the introduction of new and modified products or services, financing plans, working capital needs and sources of liquidity. These\nforward-looking statements are based on management\x92s beliefs and assumptions, which in turn are based on currently available information. Important risks and assumptions relating to the forward-looking statements include, without limitation:\n(1) the company\x92s ability to expand in new and existing markets; (2) demand for the company\x92s products and services; (3) the cost of product development; (4) the timely completion, market demand and acceptance of the company\x92s new\npharmacy and information products; (5) competitive forces; (6) gains in market share; (7) industry conditions affecting the company\x92s customers; (8) expected pricing levels; (9) expected growth of revenue and net income; (10) the timing and\ncost of planned capital expenditures; (11) the availability of capital to invest in business growth and expansion; (12) the timing of recognition of certain revenue; (13) access to data from suppliers; (14) the potential for information or network\nservices interruptions; (15) adequate protection of proprietary technology; (16) unanticipated changes in accounting rules and/or interpretations; (17) complex state and federal regulations and its impact on the demand for information products or\navailability of certain data; (18) expected outcomes and cost of any regulatory action or pending litigation; (19) expected synergies relating to acquisitions, joint ventures and strategic alliances; (20) the timing of, and expected proceeds from\nthe disposition of certain assets; (21) the company\x92s ability to maintain compliance with certain restrictive debt covenants or obtain a waiver and/or amendments to its credit agreements; and (22) the company\x92s substantial indebtedness,\nwhich could adversely affect its financial condition, results of operations and liquidity. Many of these risk factors and assumptions are beyond the company\x92s ability to control or predict, and are not intended to represent a complete list of\nall risks and uncertainties inherent in the company\x92s business, and should be read in conjunction with the more detailed cautionary statements included in NDCHealth\x92s Annual Report on Form 10-K for the fiscal year ended May 28, 2004 and\nother company filings with the Securities and Exchange Commission. The company believes its forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on the\ncompany\x92s current assumptions and expectations. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update publicly any of them in light of new information or future events.\n', u' ', u'\xa0', u' ', u'- more - ', u'\n', u'\n', u'NDCHealth Reports Fiscal First Quarter Results ', u' ', u'Page 5 ', u' ', u'\xa0', u' ', u'About NDCHealth\n', u' ', u'\xa0', u' ', u'NDCHealth is uniquely positioned in healthcare as a\nleading provider of point-of-care systems, electronic connectivity and information solutions to pharmacies, hospitals, physicians, pharmaceutical manufacturers and payers. ', u' ', u'\xa0', u' ', u'# # # ', u' ', u'\xa0', u' ', u'Contact:', u' ', u' ', u'Robert Borchert ', u' ', u'VP \x96 Investor Relations ', u' ', u'404-728-2906 ', u' ', u'robert.borchert@ndchealth.com ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'a.', u'\n', u'EBITDA, a non-GAAP measure, can be derived from the company\x92s Unaudited Condensed Consolidated Statements of Operations, and is defined as Operating Income before Depreciation\nand Amortization, and Restructuring and Other Charges. Reconciliation of EBITDA to the most directly comparable GAAP financial measure is provided in an accompanying table. ', u'\n', u'\n', u'\n', u'b.', u'\n', u'Free cash flow, a non-GAAP measure, can be derived from the company\x92s Unaudited Condensed Consolidated Statements of Cash Flows, and is defined as net cash (used in) provided\nby operating activities less capital expenditures and dividends paid. Reconciliation of free cash flow to the most directly comparable GAAP financial measure is provided in an accompanying table. ', u'\n', u'\n', u'CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ', u' ', u'NDCHealth Corporation and Subsidiaries ', u' ', u'(Unaudited) ', u' ', u'\xa0', u' ', u'(In thousands, except per share data) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Quarter Ended', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'August 27,', u'2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'August 29,', u'2003', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Revenue:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Network Services and Systems', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'57,535', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'63,058', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Information Management', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'34,943', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'35,941', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Pharmacy Benefits Services', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'16,232', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4,642', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'108,710', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'103,641', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Operating Expenses:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Cost of Service', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'66,120', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'51,426', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Sales, General and Administrative', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'23,772', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'22,055', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Depreciation and Amortization', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'10,621', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'8,579', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Restructuring and Other Charges', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'1,499', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'100,513', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'83,559', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'8,197', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'20,082', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Other Income (Expense):', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Interest and Other Income', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'65', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'102', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Interest and Other Expense', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(6,404', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(7,413', u'\n', u')', u'\n', u'\n', u' ', u'Minority Interest in Earnings', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(108', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(151', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(6,447', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(7,462', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Income from Continuing Operations before Income Taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'1,750', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'12,620', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Provision for Income Taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'683', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4,732', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Income from Continuing Operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'1,067', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'7,888', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Loss from Discontinued Operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(8,065', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(534', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Net (Loss) Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(6,998', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'7,354', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Basic (Loss) Earnings Per Share:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Continuing Operations', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'0.03', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'0.23', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Discontinued Operations', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(0.23', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(0.02', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Basic (Loss) Earnings Per Share', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(0.20', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'0.21', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Shares', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'35,638', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'34,746', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Diluted Earnings (Loss) Per Share:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Continuing Operations', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'0.03', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'0.22', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Discontinued Operations', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(0.22', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(0.02', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Diluted (Loss) Earnings Per Share', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(0.19', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'0.21', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Shares', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'36,002', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'35,114', u'\n', u'\xa0', u'\n', u' ', u'\xa0', u'\n', u'\n', u'CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS ', u' ', u'NDCHealth Corporation and Subsidiaries ', u' ', u'(Unaudited) ', u' ', u'\xa0', u' ', u'(In thousands) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Three Months Ended', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u' ', u'August\xa027,', u' ', u'2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'August\xa029,', u' ', u'2003', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Cash flows from operating activities:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Net (loss) income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(6,998', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'7,354', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Loss on discontinued operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'8,065', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'534', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Non-cash restructuring and other charges', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'101', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Depreciation and amortization', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'10,621', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'8,579', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred income taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'505', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4,215', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Allowance for doubtful accounts', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'2,016', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'2,296', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Other, net', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'1,316', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'1,195', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'15,525', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'24,274', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Changes in assets and liabilities, net of the effects of acquisitions:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accounts receivable', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(928', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(4,047', u'\n', u')', u'\n', u'\n', u' ', u'Prepaid expenses and other assets', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'4,417', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'5,130', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accounts payable and accrued liabilities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(15,997', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'2,968', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accrued interest on long-term debt', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(5,379', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(5,530', u'\n', u')', u'\n', u'\n', u' ', u'Deferred revenue', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(4,960', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,903', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Net cash (used in) provided by operating activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(7,322', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'20,892', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Cash flows from investing activities:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Capital expenditures', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(10,339', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(13,803', u'\n', u')', u'\n', u'\n', u' ', u'Acquisitions and other investing activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(1,838', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(5,516', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Net cash used in investing activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(12,177', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(19,319', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Cash flows from financing activities:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Net borrowings under lines of credit', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'38,500', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Net principal payments under long-term debt arrangements', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(29,722', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(488', u'\n', u')', u'\n', u'\n', u' ', u'Net cash used in refinancing activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(154', u'\n', u')', u'\n', u'\n', u' ', u'Net (repurchases) issuances related to stock activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(70', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'654', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Dividends paid', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(1,439', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,408', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Net cash provided by (used in) financing activities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'7,269', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,396', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Net cash used in discontinued operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(9,547', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,350', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Decrease in cash and cash equivalents', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(21,777', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,173', u'\n', u')', u'\n', u'\n', u' ', u'Cash and cash equivalents, beginning of period', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'27,617', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'15,150', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Cash and cash equivalents, end of period', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'5,840', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'13,977', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u' ', u'\xa0', u'\n', u'\n', u'CONDENSED CONSOLIDATED BALANCE SHEETS ', u' ', u'NDCHealth Corporation and Subsidiaries ', u' ', u'(Unaudited)', u' ', u' ', u' ', u'\xa0', u' ', u'(In thousands, except share data) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u' ', u'August 27,', u' ', u'2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'May 28,', u' ', u'2004', u'\n', u'\xa0', u'\n', u'\n', u' ', u'ASSETS', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Current Assets:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Cash and Cash Equivalents', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'5,840', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'27,617', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accounts Receivable (Less Allowance of $7,651 and $7,612)', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'68,070', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'69,066', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred Income Taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'6,515', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'28,441', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Prepaid Expenses', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'19,798', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'22,063', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Other Current Assets', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'13,555', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'15,667', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Total Assets of Discontinued Operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'61,218', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'70,459', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Current Assets', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'174,996', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'233,313', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Property and Equipment, Net', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'79,222', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'77,052', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Capitalized External Use Software, Net', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'64,389', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'64,038', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Goodwill', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'365,248', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'364,743', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Intangible Assets, Net', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'69,291', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'71,760', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Debt Issuance Cost', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'12,743', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'12,963', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred Income Taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,003', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Other Assets', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'23,667', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'22,683', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Assets', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'792,559', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'846,552', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'LIABILITIES AND STOCKHOLDERS\x92 EQUITY', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Current Liabilities:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Current Portion of Long-term Debt', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'44,450', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'33,656', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Trade Accounts Payable', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'20,799', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'29,693', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accrued Compensation and Benefits', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'4,508', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'6,205', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Accrued Interest', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'5,544', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'10,923', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred Revenue', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'43,766', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'45,981', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Other Accrued Liabilities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'31,257', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'35,212', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Total Liabilities of Discontinued Operations', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'15,246', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'24,761', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Current Liabilities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'165,570', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'186,431', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Deferred Revenue', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'4,497', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'7,208', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred Income Taxes', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'18,414', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Other Non-current Liabilities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'26,203', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'27,949', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Long-term Debt', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'267,603', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'269,619', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Liabilities', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'463,873', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'509,621', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Commitments and Contingencies', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Minority Interest in Equity of Subsidiaries', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'1,420', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'1,313', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Stockholders\x92 Equity:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Preferred Stock, par value $1.00 per share; 1,000,000 shares authorized, none issued', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Common Stock, par value $.125 per share; 200,000,000 shares authorized; 35,989,794 and 36,106,641 shares issued, respectively.', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'4,499', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4,513', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Capital in excess of par value', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'244,971', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'245,301', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Treasury Stock', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(108', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Retained Earnings', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'79,095', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'87,532', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Deferred Compensation and Other', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(6,736', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(7,694', u'\n', u')', u'\n', u'\n', u' ', u'Other Comprehensive Income', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'5,545', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'5,966', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Stockholders\x92 Equity', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'327,266', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'335,618', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Total Liabilities and Stockholders\x92 Equity', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'792,559', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'846,552', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'EX-99.2\n', u'3\n', u'dex992.htm\n', u'EBITDA RECONCILIATION\n', u'\n', u'EBITDA Reconciliation', u'\n', u'Exhibit 99.2 ', u' ', u'\xa0', u' ', u'EBITDA RECONCILIATION ', u' ', u'NDCHealth\nCorporation and Subsidiaries ', u' ', u'\xa0', u' ', u'EBITDA is defined as Operating Income before\nDepreciation and Amortization, and Restructuring and Other Charges. EBITDA is not a Generally Accepted Accounting Principles (GAAP) measurement and may not be comparable to EBITDA reported by other companies. Management believes EBITDA provides\ninvestors with additional useful information to measure the company\x92s performance as it excludes certain items that either do not impact the company\x92s cash flows or which management believes are not reflective of the company\x92s core\noperating results over time. ', u' ', u'\xa0', u' ', u'Reconciliation to the most directly comparable\nGAAP financial measure for the three months ended August 27, 2004 and August 29, 2003 to our results determined under GAAP is provided below. ', u' ', u'\xa0', u' ', u'($ in thousands) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Three Months Ended', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'August\xa027,', u'2004', u'\n', u'\xa0\xa0', u'\n', u' ', u'August\xa029,', u' ', u'2003', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'8,197', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'20,082', u'\n', u'\n', u' ', u'Depreciation and Amortization', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'10,621', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'8,579', u'\n', u'\n', u' ', u'Restructuring and Other Charges', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\x97\xa0\xa0', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'1,499', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u' ', u'EBITDA', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'18,818', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'30,160', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'EX-99.3\n', u'4\n', u'dex993.htm\n', u'FREE CASH FLOW RECONCILIATION.\n', u'\n', u'Free Cash Flow Reconciliation.', u'\n', u'Exhibit 99.3 ', u' ', u'\xa0', u' ', u'FREE CASH FLOW RECONCILIATION ', u' ', u'NDCHealth Corporation and Subsidiaries ', u' ', u'\xa0', u' ', u'Free cash flow is\ndefined as net cash from operations less capital expenditures and dividends paid. Free cash flow is not a Generally Accepted Accounting Principles (GAAP) measurement and may not be comparable to free cash flow reported by other companies. In light\nof the company\x92s goal to reduce its levels of senior debt and interest expense, management believes free cash flow is a meaningful measure of its ability to generate cash for the payment of debt. ', u' ', u'\xa0', u' ', u'Reconciliation to the most directly comparable GAAP financial measure for the three months\nended August 27, 2004 and August 29, 2003 to our results determined under GAAP is provided below. ', u' ', u'\xa0', u' ', u'(In thousands) ', u' ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Three Months Ended', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'August\xa027,', u'2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'August\xa029,', u' ', u'2003', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Net cash (used in) provided by operating activities', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(7,322', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'20,892', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Capital expenditures', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(10,339', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(13,803', u'\n', u')', u'\n', u'\n', u' ', u'Dividends paid', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'(1,439', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'(1,408', u'\n', u')', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Free cash flow', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(19,100', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'5,681', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'EX-99.4\n', u'5\n', u'dex994.htm\n', u'SEGMENT FINANCIAL SUMMARY.\n', u'\n', u'Segment Financial Summary.', u'\n', u'Exhibit 99.4 ', u' ', u'\xa0', u' ', u'SEGMENT FINANCIAL SUMMARY ', u' ', u'NDCHealth\nCorporation and Subsidiaries ', u' ', u'\xa0', u' ', u'(from\ncontinuing operations) ', u' ', u'($ in thousands) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Fiscal 2004', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Fiscal\xa02005', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'Q1/Q1', u' ', u'Y-Y', u' ', u'%\xa0Change', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Q4/Q1', u'Sequential', u'%\xa0Change', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Qtr 1', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Qtr 2', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Qtr 3', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Qtr 4', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'Qtr 1', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Network Services and Systems:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Revenue', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'63,058', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'66,859', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'66,248', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'60,881', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'57,535', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-8.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-5.5', u'\n', u'%', u'\n', u'\n', u' ', u'Cost of Service', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'28,011', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'29,683', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'28,425', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'30,384', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'30,678', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'9.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'1.0', u'\n', u'%', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'15,001', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'15,684', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'15,136', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'7,320', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'5,683', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-62.1', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-22.4', u'\n', u'%', u'\n', u'\n', u' ', u'% margin', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'23.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'23.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'22.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'12.0', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'9.9', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Information Management:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Revenue', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'35,941', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'38,762', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'37,918', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'36,708', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'34,943', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-2.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-4.8', u'\n', u'%', u'\n', u'\n', u' ', u'Cost of Service', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'19,730', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'19,713', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'20,106', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'20,982', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'20,379', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'3.3', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-2.9', u'\n', u'%', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'6,280', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'8,551', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'7,741', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'2,355', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'2,296', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-63.4', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-2.5', u'\n', u'%', u'\n', u'\n', u' ', u'% margin', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'17.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'22.1', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'20.4', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'6.4', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'6.6', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Pharmacy Benefit Services:', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Revenue', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'4,642', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'4,802', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'6,585', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'13,879', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'16,232', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'249.7', u'\n', u'%', u'\n', u'\xa0', u'\n', u'17.0', u'\n', u'%', u'\n', u'\n', u' ', u'Cost of Service', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'3,685', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'3,653', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'5,663', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'13,011', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'15,063', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'308.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'15.8', u'\n', u'%', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'300', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'531', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'164', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(118', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'218', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-27.3', u'\n', u'%', u'\n', u'\xa0', u'\n', u'284.7', u'\n', u'%', u'\n', u'\n', u' ', u'% margin', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'6.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'11.1', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'2.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-0.9', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'1.3', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Other:*', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'(1,499', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(1,422', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u' \x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(622', u'\n', u')', u'\n', u'\xa0', u'\n', u'$', u'\n', u' \x97\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'nm', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'nm', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'NDCHealth - Total', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Revenue', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'103,641', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'110,423', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'110,751', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'111,468', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'108,710', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'4.9', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-2.5', u'\n', u'%', u'\n', u'\n', u' ', u'Cost of Service', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'51,426', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'53,049', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'54,194', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'64,377', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'66,120', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'28.6', u'\n', u'%', u'\n', u'\xa0', u'\n', u'2.7', u'\n', u'%', u'\n', u'\n', u' ', u'Operating Income', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'20,082', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'23,344', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'23,041', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'8,935', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'$', u'\n', u'8,197', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'-59.2', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-8.3', u'\n', u'%', u'\n', u'\n', u' ', u'% margin', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'19.4', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'21.1', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'20.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'8.0', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'7.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'*', u'\n', u'Includes Restructuring and Other Charges not allocated to an Operating Segment. ', u'\n', u'\n', u'\n', u'\n', u'EX-99.5\n', u'6\n', u'dex995.htm\n', u'NETWORK SERVICES AND SYSTEMS SEGMENT REVENUE BY CUSTOMER GROUP.\n', u'\n', u'Network Services and Systems Segment Revenue by Customer Group.', u'\n', u'Exhibit 99.5 ', u' ', u'\xa0', u' ', u'NETWORK SERVICES AND SYSTEMS SEGMENT REVENUE BY CUSTOMER GROUP ', u' ', u'NDCHealth Corporation and Subsidiaries ', u' ', u'\xa0', u' ', u'(from continuing operations) ', u' ', u'($ in thousands) ', u' ', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Fiscal 2004', u'\n', u'\xa0\xa0', u'\n', u'Fiscal\xa02005', u'\n', u'\xa0\xa0', u'\n', u' ', u'Q1/Q1', u' ', u'Y-Y', u' ', u'%\xa0Change', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'Q4/Q1', u'Sequential', u' ', u'%\xa0Change', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'Qtr 1', u'\n', u'\xa0\xa0', u'\n', u'Qtr 2', u'\n', u'\xa0\xa0', u'\n', u'Qtr 3', u'\n', u'\xa0\xa0', u'\n', u'Qtr 4', u'\n', u'\xa0\xa0', u'\n', u'Qtr 1', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Pharmacy', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'34,807', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'36,567', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'38,848', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'37,116', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'33,949', u'\n', u'\xa0\xa0', u'\n', u'-2.5', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-8.5', u'\n', u'%', u'\n', u'\n', u' ', u'Hospital', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'14,402', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'14,361', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'13,156', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'14,154', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'14,129', u'\n', u'\xa0\xa0', u'\n', u'-1.9', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-0.2', u'\n', u'%', u'\n', u'\n', u' ', u'Physician', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'9,937', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'12,353', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'10,819', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'6,225', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'5,983', u'\n', u'\xa0\xa0', u'\n', u'-39.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-3.9', u'\n', u'%', u'\n', u'\n', u' ', u'Other', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,912', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,578', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,425', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,386', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'3,474', u'\n', u'\xa0\xa0', u'\n', u'-11.2', u'\n', u'%', u'\n', u'\xa0', u'\n', u'2.6', u'\n', u'%', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' ', u'Total', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'63,058', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'66,859', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'66,248', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'60,881', u'\n', u'\xa0\xa0', u'\n', u'$', u'\n', u'57,535', u'\n', u'\xa0\xa0', u'\n', u'-8.8', u'\n', u'%', u'\n', u'\xa0', u'\n', u'-5.5', u'\n', u'%', u'\n', u'\n', u'\xa0', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n-----END PRIVACY-ENHANCED MESSAGE-----\n']